Loading...
XSHG
600568
Market cap433mUSD
Jul 17, Last price  
1.60CNY
Name

Zhongzhu Healthcare Holding Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
4.84
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.30%
Rev. gr., 5y
2.20%
Revenues
639m
+26.21%
451,991,709811,210,4881,481,284,6451,860,169,5842,480,654,1672,021,809,949449,922,594464,148,862627,889,303790,638,3501,069,987,066921,782,3721,098,977,643981,023,762572,861,387696,172,449727,473,784581,059,366505,971,358638,562,819
Net income
-344m
8,756,1580018,435,74340,974,186146,547,84173,765,178183,057,41460,226,00662,430,25832,406,40373,411,041294,174,099169,343,6390014,591,07400-343,935,382
CFO
4m
-86.04%
2,746,85357,267,28448,494,5403,575,32590,740,76300003,556,57614,338,135189,045,815296,576,55000614,570,785248,153,57794,043,01025,524,6773,561,997
Dividend
Aug 07, 20180.02 CNY/sh

Profile

Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs. In addition, it researches and develops drugs, such as recombinant human endostatin adenovirus injection, which is an anticancer gene therapy; Genistein capsule for the treatment of postmenopausal osteoporosis; and motherwort that is primarily a gynecological drug. Further, the company offers medical instruments, including radiation therapy, hyperthermia, phototherapy, and ultrasound diagnosis, as well as develops imaging breast tumor detection systems. Additionally, it offers medical services. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co.,Ltd in June 2016. Zhongzhu Healthcare Holding Co.,Ltd was founded in 1970 and is headquartered in Qianjiang, China.
URL
http://www.zz600568.com
IPO date
May 18, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
638,563
26.21%
505,971
-12.92%
Cost of revenue
797,330
481,192
Unusual Expense (Income)
NOPBT
(158,767)
24,779
NOPBT Margin
4.90%
Operating Taxes
16
Tax Rate
NOPAT
(158,783)
24,779
Net income
(343,935)
 
Dividends
(103)
Dividend yield
0.00%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,668
14,477
Long-term debt
25,529
517,077
Deferred revenue
7,413
Other long-term liabilities
6,009
419
Net debt
(904,287)
(407,773)
Cash flow
Cash from operating activities
3,562
25,525
CAPEX
(27,259)
Cash from investing activities
(41,217)
Cash from financing activities
(11,491)
FCF
142,726
543,561
Balance
Cash
583,978
612,184
Long term investments
348,506
327,143
Excess cash
900,556
914,029
Stockholders' equity
(398,377)
2,248,908
Invested Capital
3,010,281
2,118,071
ROIC
1.02%
ROCE
0.80%
EV
Common stock shares outstanding
2,023,149
1,992,870
Price
1.72
-8.51%
1.88
-4.08%
Market cap
3,479,817
-7.12%
3,746,595
-4.08%
EV
2,711,996
3,477,753
EBITDA
(79,200)
124,374
EV/EBITDA
27.96
Interest
7,718
15,000
Interest/NOPBT
60.53%